Accenture Life Sciences Blog
Pharmaceutical and medical technology companies face both complexity and opportunity when navigating the current healthcare landscape. Accenture experts will share their insights and opinions on how pharmaceutical and medical technology companies can rethink, reshape and restructure for better patient outcomes during complex times.
Chief procurement officers (CPOs) play an important role in achieving efficiency in life sciences operations. Not only are they under constant pressure to reduce costs—they have to do this while driving innovation. Accenture recently presented at ...
Last week, I attended the BIO International Convention in Chicago. This year’s convention brought over 16,000 attendees to what is considered one of the anchor biotech events of the year. Being at Chicago’s McCormick Place, you would think that a ...
By:
Guest Blogger Rob Saiter
When life sciences companies transform their business through technology, they rely on a number of factors to make it work. The recent Accenture Oracle Leadership Council (AOLC) focused on how leaders across all industries combine business vision,...
High performance in life sciences often comes down to focus and speed-to-value. But being right, fast and efficient doesn’t happen overnight—these skills can only be achieved through a seamless integration of the R&D, supply chain and commerci...
When it comes to building capabilities in the “new normal,” life sciences companies will not be going at it alone. In Life sciences companies plan to go digital, I shared how pharma companies are turning to technology to reduce costs and respond t...
Every business is now a digital business, and life sciences companies are embracing this fact. Last week, I introduced the customer engagement revolution. This week, I’ll look at how the companies we surveyed plan to meet their cost reduction goal...
We are entering the customer engagement revolution. Life sciences companies striving for growth in the “new normal” will not only need to reach customers in mature and emerging markets, they’ll need to reach these customers quickly, cost effective...
“Lung-on-a-chip” may sound right out of a movie, but scientists at GlaxoSmithKline (GSK) have made the technology a reality. GSK worked with the University of Southern Alabama and the Wyss Institute-Harvard to produce a device that mimics the mech...
Last week, I looked at the four stages of supply chain maturity. This week, I’m explaining how you move from stage to stage without getting caught up in one for too long.
Identifying the capabilities
Accenture has identified eight core capabili...
We kicked off the Massachusetts Biotechnology (MassBio) Council annual meeting a few weeks ago, discussing the progress in personalized medicine—in the end, giving it a new definition.
I moderated a panel, which included Kevin Krenitsky, MD, Chi...
Next >>